Drug intelligence / Profile preview

methacetin

Development stage
Unknown
Lead developer
Exalenz Bioscience
Modality
Small Molecules
Administration
Oral
01

Overview

**Methacetin** is a synthetic aromatic ether and member of the acetamide class, structurally related to paracetamol (acetaminophen). It is used primarily as a diagnostic agent in the form of labeled (^13C)-methacetin for the non-invasive assessment of liver function. Methacetin is metabolized in the liver by cytochrome P450 1A2 (CYP1A2) via O-demethylation to produce acetaminophen and formaldehyde. The latter is further metabolized to CO₂, which can be measured in breath tests. The methacetin breath test is sensitive and non-invasive, and is particularly useful in detecting liver dysfunction, assessing microsomal liver function, and predicting disease progression in chronic liver conditions and cirrhosis[5][7]. Methacetin is not used for direct therapy but exclusively as a diagnostic tool.

Other names
Acetamide, N-(4-methoxyphenyl)-p-acetanisididep-acetanisidinep-methoxyacetanilideaceto-p-anisidideacetyl-p-anisidinemetacetinN-acetyl-p-methoxyaniline4-methoxyacetanilide4'-methoxyacetanilideN-acetyl-p-anisidineaceto-p-anisidineacetanilide, 4'-methoxy-N-(4-methoxyphenyl)acetamideN-(p-methoxyphenyl)acetamide4-(acetylamino)anisoleNSC 4687NSC4687NSC-4687acetanilide, 4-methoxyN-(4-methoxyphenyl)acetic acid amide
02

Targets

CYP1A2 (Cytochrome P450 1A2)

Beyond the preview

Go deeper on methacetin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methacetin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call